Notably, LINC00847 was transcriptionally activated by E2F1 and contributed to NSCLC progression through targeting modulating miR-147a/IFITM1 axis (Li H. et al., 2021). The gene discussed is E2F1; the disease is non-small cell lung carcinoma.